Analystreport

Magenta Therapeutics, Inc. (NASDAQ: MGTA) had its price target lowered by analysts at B. Riley from $13.00 to $6.00.

Magenta Therapeutics, Inc.  (MGTA) 
Last magenta therapeutics, inc. earnings: 11/13 08:00 am Check Earnings Report